DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107

  • Matthew P. Morrow
  • , Elisabeth Gillespie
  • , Albert Sylvester
  • , Milan R. Amin
  • , Peter C. Belafsky
  • , Simon R. Best
  • , Aaron D. Friedman
  • , Adam M. Klein
  • , David G. Lott
  • , Ted Mau
  • , Randal C. Paniello
  • , Seth M. Pransky
  • , Nabil F. Saba
  • , Grace S. Tan
  • , Sadie Wisotsky
  • , Sarah A. Marcus
  • , Emma L. Reuschel
  • , Katherine S. Reed
  • , David B. Weiner
  • , Michael Dallas
    • Jeffrey M. Skolnik

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology